PMC:7195088 / 63301-63498 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1861","span":{"begin":136,"end":140},"obj":"Gene"},{"id":"1872","span":{"begin":68,"end":79},"obj":"Chemical"}],"attributes":[{"id":"A1861","pred":"tao:has_database_id","subj":"1861","obj":"Gene:3569"},{"id":"A1872","pred":"tao:has_database_id","subj":"1872","obj":"MESH:C502936"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, it should be noted that the optimal time for administering tocilizumab has not yet been fully elucidated; nor is there a clear IL-6 threshold associated with progression to severe disease."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T109","span":{"begin":136,"end":138},"obj":"Body_part"}],"attributes":[{"id":"A109","pred":"fma_id","subj":"T109","obj":"http://purl.org/sig/ont/fma/fma86578"}],"text":"However, it should be noted that the optimal time for administering tocilizumab has not yet been fully elucidated; nor is there a clear IL-6 threshold associated with progression to severe disease."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T353","span":{"begin":80,"end":83},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T354","span":{"begin":128,"end":129},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"However, it should be noted that the optimal time for administering tocilizumab has not yet been fully elucidated; nor is there a clear IL-6 threshold associated with progression to severe disease."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T84369","span":{"begin":68,"end":79},"obj":"Chemical"},{"id":"T38193","span":{"begin":136,"end":138},"obj":"Chemical"}],"attributes":[{"id":"A72262","pred":"chebi_id","subj":"T84369","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"},{"id":"A9438","pred":"chebi_id","subj":"T38193","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A56942","pred":"chebi_id","subj":"T38193","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"However, it should be noted that the optimal time for administering tocilizumab has not yet been fully elucidated; nor is there a clear IL-6 threshold associated with progression to severe disease."}

{"project":"LitCovid-sentences","denotations":[{"id":"T455","span":{"begin":0,"end":197},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, it should be noted that the optimal time for administering tocilizumab has not yet been fully elucidated; nor is there a clear IL-6 threshold associated with progression to severe disease."}